Company intelligence / Profile preview

Sansum Diabetes Research Institute

Santa Barbara, California, United States

Ownership: Private
Employees: ~102
Development stage: Other

Overview

SDRI conducts clinical research on diabetes management technologies and therapeutics, including pivotal trials for automated insulin delivery systems and continuous glucose monitoring devices. The institute also provides clinical care and education services focused on diabetes treatment and prevention.

Therapeutic areas: Endocrinology
Modalities: DeviceSmall moleculeBiologic
Industry: Academic Hospital/University/Research

Partnerships

AbbottDexcomInsuletEli LillyMannkindMedtronic DiabetesNovo NordiskSanofiTandem Diabetes CareJDRFNational Institutes of HealthHarvard UniversityUniversity of California, Santa BarbaraMayo Clinic

Beyond the preview

Go deeper on Sansum Diabetes Research Institute.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sansum Diabetes Research Institute.

Explore the full profile